Matthew T Rondina1, McKenzie Carlisle2, Tamra Fraughton3, Samuel M Brown4, Russell R Miller5, Estelle S Harris6, Andrew S Weyrich7, Guy A Zimmerman6, Mark A Supiano8, Colin K Grissom4. 1. Division of General Internal Medicine, Program in Molecular Medicine. 2. Program in Molecular Medicine. 3. Program in Molecular Medicine, Department of Psychology, and. 4. Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Utah, Salt Lake City. Division of Pulmonary and Critical Care Medicine,Intermountain Medical Center, Murray, Utah. 5. Division of Pulmonary and Critical Care Medicine,Intermountain Medical Center, Murray, Utah. 6. Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Utah, Salt Lake City. 7. Program in Molecular Medicine, Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Utah, Salt Lake City. 8. Division of Geriatric Medicine and Salt Lake City VA GRECC, University of Utah.
Abstract
BACKGROUND: Aging-related changes in platelet and monocyte interactions may contribute to adverse outcomes in sepsis but remain relatively unexamined. We hypothesized that differential platelet-monocyte aggregate (PMA) formation in older septic patients alters inflammatory responses and mortality. METHODS: We prospectively studied 113 septic adults admitted to the intensive care unit with severe sepsis or septic shock. Patients were dichotomized a priori into one of two groups: older (age ≥ 65 years, n = 28) and younger (age < 65 years, n = 85). PMA levels were measured in whole blood via flow cytometry within 24 hours of admission. Plasma levels of IL-6 and IL-8, proinflammatory cytokines produced by monocytes upon PMA formation, were determined by commercial assays. Patients were followed for the primary outcome of 28-day, all-cause mortality. RESULTS: Elevated PMA levels were associated with an increased risk of mortality in older septic patients (hazard ratio for mortality 5.64, 95% confidence interval 0.64-49.61). This association remained after adjusting for potential confounding variables in multivariate regression. Receiver operating curve analyses demonstrated that PMA levels greater than or equal to 8.43% best predicted 28-day mortality in older septic patients (area under the receiver operating curve 0.82). Plasma IL-6 and IL-8 levels were also significantly higher in older nonsurvivors. In younger patients, neither PMA levels nor plasma monokines were significantly associated with mortality. CONCLUSIONS: Increased PMA formation, and associated proinflammatory monokine synthesis, predicts mortality in older septic patients. Although larger studies are needed, our findings suggest that heightened PMA formation in older septic patients may contribute to injurious inflammatory responses and an increased risk of mortality.
BACKGROUND: Aging-related changes in platelet and monocyte interactions may contribute to adverse outcomes in sepsis but remain relatively unexamined. We hypothesized that differential platelet-monocyte aggregate (PMA) formation in older septic patients alters inflammatory responses and mortality. METHODS: We prospectively studied 113 septic adults admitted to the intensive care unit with severe sepsis or septic shock. Patients were dichotomized a priori into one of two groups: older (age ≥ 65 years, n = 28) and younger (age < 65 years, n = 85). PMA levels were measured in whole blood via flow cytometry within 24 hours of admission. Plasma levels of IL-6 and IL-8, proinflammatory cytokines produced by monocytes upon PMA formation, were determined by commercial assays. Patients were followed for the primary outcome of 28-day, all-cause mortality. RESULTS: Elevated PMA levels were associated with an increased risk of mortality in older septic patients (hazard ratio for mortality 5.64, 95% confidence interval 0.64-49.61). This association remained after adjusting for potential confounding variables in multivariate regression. Receiver operating curve analyses demonstrated that PMA levels greater than or equal to 8.43% best predicted 28-day mortality in older septic patients (area under the receiver operating curve 0.82). Plasma IL-6 and IL-8 levels were also significantly higher in older nonsurvivors. In younger patients, neither PMA levels nor plasma monokines were significantly associated with mortality. CONCLUSIONS: Increased PMA formation, and associated proinflammatory monokine synthesis, predicts mortality in older septic patients. Although larger studies are needed, our findings suggest that heightened PMA formation in older septic patients may contribute to injurious inflammatory responses and an increased risk of mortality.
Authors: Matthew T Rondina; BreAnna Brewster; Colin K Grissom; Guy A Zimmerman; Diana H Kastendieck; Estelle S Harris; Andrew S Weyrich Journal: Chest Date: 2012-03-01 Impact factor: 9.410
Authors: Matteo Cesari; Stephen B Kritchevsky; Christiaan Leeuwenburgh; Marco Pahor Journal: Antioxid Redox Signal Date: 2006 Mar-Apr Impact factor: 8.401
Authors: Matthew T Rondina; Colin K Grissom; Shaohua Men; Estelle S Harris; Hansjorg Schwertz; Guy A Zimmerman; Andrew S Weyrich Journal: Thromb Res Date: 2011-12-16 Impact factor: 3.944
Authors: Donya Mohebali; David Kaplan; McKenzie Carlisle; Mark A Supiano; Matthew T Rondina Journal: J Am Geriatr Soc Date: 2014-02-10 Impact factor: 5.562
Authors: Matthew R Baldwin; Wazim R Narain; Hannah Wunsch; Neil W Schluger; Joseph T Cooke; Mathew S Maurer; John W Rowe; David J Lederer; Peter B Bach Journal: Chest Date: 2013-04 Impact factor: 9.410
Authors: Elizabeth A Middleton; Jesse W Rowley; Robert A Campbell; Colin K Grissom; Samuel M Brown; Sarah J Beesley; Hansjörg Schwertz; Yasuhiro Kosaka; Bhanu K Manne; Krystin Krauel; Neal D Tolley; Alicia S Eustes; Li Guo; Robert Paine; Estelle S Harris; Guy A Zimmerman; Andrew S Weyrich; Matthew T Rondina Journal: Blood Date: 2019-07-31 Impact factor: 22.113
Authors: Rebecca Y Klinger; Mary Cooter; Miles Berger; Mihai V Podgoreanu; Mark Stafford-Smith; Thomas L Ortel; Ian J Welsby; Jerrold H Levy; Henry M Rinder; Mark F Newman; Joseph P Mathew Journal: Can J Anaesth Date: 2016-07-28 Impact factor: 5.063
Authors: Robert A Campbell; Zechariah Franks; Anish Bhatnagar; Jesse W Rowley; Bhanu K Manne; Mark A Supiano; Hansjorg Schwertz; Andrew S Weyrich; Matthew T Rondina Journal: J Immunol Date: 2017-11-22 Impact factor: 5.422
Authors: Callie Frey; Antigoni G Koliopoulou; Emilie Montenont; Neal D Tolley; Hadi Javan; Stephen H McKellar; Stavros G Drakos; Craig H Selzman; Matthew T Rondina Journal: Platelets Date: 2020-01-14 Impact factor: 3.862
Authors: David Kaplan; T Charles Casper; C Gregory Elliott; Shaohua Men; Robert C Pendleton; Larry W Kraiss; Andrew S Weyrich; Colin K Grissom; Guy A Zimmerman; Matthew T Rondina Journal: Chest Date: 2015-11 Impact factor: 9.410